What is it about?

Azithromycin slows progression of bronchiolitis obliterans syndrome. Long term survival was not affected by randomization to placebo. Randomized placebo controlled trials in lung transplantation patients is feasible, effective and safe.

Featured Image

Read the Original

This page is a summary of: Long-term effect of azithromycin in bronchiolitis obliterans syndrome, BMJ Open Respiratory Research, October 2019, BMJ,
DOI: 10.1136/bmjresp-2019-000465.
You can read the full text:

Read

Contributors

The following have contributed to this page